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Historically, sex- or gender-related differ-
ences in addictions have been understud-
ied. When neglected, both sexes may not
receive the full benefit of medical research.
Although hormone fluctuations in women
are rarely investigated with respect to treat-
ments, levels of estrogen and progesterone
may have large impacts on the effica-
cies of behavioral or pharmaceutical inter-
ventions (1–7). The National Institutes
of Health (NIH) have been advocating
for investigating gender-related differences
and hormonal influences (8), including
with respect to impulse control and its
contributions to addictions. Despite the
importance of studying sex differences,
the standard integration of sex-difference
considerations, including in preclinical
research using cell lines and animals, has
yet to occur.
Sex differences are present in personal-
ity traits and behaviors, such as impulsiv-
ity, that have been associated with addic-
tions (both substance and non-substance).
Impulsivity has been defined as a tendency
to act with little foresight or little con-
sideration of future consequences (9, 10).
Impulsivity is a complex construct that may
be separated into specific factors; two main
domains that can be measured in the labo-
ratory include impulsive action and impul-
sive choice (11). Both impulsive action and
choice have been associated with drug use,
in both a predictive fashion and as a result
of drug use (12, 13). Work investigating sex
differences in impulsive action in both ani-
mals and humans has shown mixed results
(14). The mixed findings may in part relate
to sex hormones, with females displaying
fluctuating levels of impulsivity dependent
on cycle phase and estrogen levels (14).
Impulsive choice has been measured
in the laboratory using delay-discounting
tasks (13, 15–17). While multiple studies
suggest that men may be more impulsive
than women, careful investigation of spe-
cific facets suggest otherwise. Women may
display greater discounting rates than men
(i.e., greater choice impulsivity); however,
reward type is relevant as men have been
found to discount real money more rapidly
than women, with women discounting
hypothetical rewards more rapidly than
men (18). Among adolescents, female
smokers appear more impulsive than male
smokers, but male control subjects appear
more impulsive than female control sub-
jects (19). Consistent with findings from
Kirby and Marakovic (18); Heyman and
Gibb (20) found that female smokers also
tend to discount the value of hypothetical
rewards more rapidly than do males.
Among heavy drinkers, women exhibit
poorer inhibitory control than men (21,
22). A study investigating the neural cor-
relates of impulsivity in non-abusing indi-
viduals who were family-history positive
for alcohol abuse found that those who
are family-history positive show greater
recruitment of brain regions involved in
addiction, inhibitory control, and executive
function compared to those without fam-
ily histories of alcoholism; however, this
effect was driven by males (23). Had gender
differences not been built into the experi-
mental design, such a finding would not
have been identified. Although there exist
strong associations between drug use and
impulsivity in both humans and animals,
with impulsivity increasing the propensity
for drug use and vice-versa (12, 13, 24,
25), few studies have investigated sex dif-
ferences, particularly in preclinical work.
The possible roles for cycle phase or circu-
lating hormones in delay-discounting-task
performance warrant further study.
Impulsivity and behavioral perfor-
mance in impulsivity tasks does not always
differ between men and women; however,
that does not mean that both sexes are
achieving similar performance in the same
way. Even when men and women perform
comparably in inhibitory tasks, different
neurobiologies may underlie the behaviors.
For example, in a recent study of gender-
related differences in neural factors asso-
ciated with performance of the stop-signal
task, men tended to show more activation
in the lentiform nucleus, parahippocampal
gyrus, posterior and anterior cingulate cor-
tices, middle and medial frontal cortices,
and thalamus, compared to women, despite
similar performance on the task (26). In
general, men and women display different
brain connectivity patterns, both in adoles-
cence and adulthood. One study found that
men show greater within-hemispheric con-
nectivity and women show greater across-
hemispheric activity, suggesting that male
brains may be better suited to facilitate con-
nectivity between perception and coordi-
nated action, whereas female brains may be
better suited to facilitate communication
between analytical and intuitive processes
(27). As neurobiological differences in
males and females start in early stages of
development (28, 29), it may be difficult to
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determine which differences are the result
of genetics, which are influenced by cycling
hormones and which may arise through
interactions and other processes. Some dif-
ferences may arise from how similarly con-
served genes across the sexes are translated
and expressed differently depending on
sex (30).
Although men and women may use the
same drugs and display the same behav-
ioral addictions, frequencies may vary by
drugs and behaviors (31). Furthermore,
addictions may present differently, have
different courses and patterns of comor-
bidity, be driven by different motivations,
and have different factors leading to relapse
(14, 32, 33). Males typically have higher
rates of drug use and are more likely to
develop dependence or abuse; however,
women may have transition from initial
use to dependence more quickly. Preclinical
and clinical data suggest an enhanced vul-
nerability to drug use with greater acquisi-
tion of drug self-administration in females
as compared to males (32, 34–40).
Given apparent sex differences in sus-
ceptibilities to drug use, sex differences
in the approach to treating drug use and
drug-use disorders are important to con-
sider in order to optimize interventions
for each sex. A recent study investigating
sex differences in the efficacy of disulfiram
in cocaine and alcohol dependence found
that women, compared to men, had poorer
treatment outcomes on several measures
of cocaine use during treatment and at
post-treatment follow-up, which was pri-
marily accounted for by disulfiram being
less effective in women than men (41).
Gonadal hormones may influence relation-
ships with treatment outcomes as estro-
gen may enhance the rewarding proper-
ties of drugs whereas progesterone may
be more protective and attenuate drug-
rewarding effects (5, 7, 42). Severity of
withdrawal symptoms may vary based on
menstrual-cycle phase (1–4). Moreover,
estrogen interactions with dopamine trans-
mission or the hypothalamic-pituitary-
adrenal (HPA) axis may partially under-
lie facilitative effects (43–45). For example,
females may be more affected by stress and
report stress as a reason for drug use and
relapse; therefore, greater activation of the
HPA axis through stress has the poten-
tial to interact with circulating estrogen
and monoamine neurotransmitters such as
dopamine and serotonin (both implicated
in rewarding and motivational aspects of
drug use and impulse control) (34, 46, 47).
Women may be more likely to engage
in addictive behaviors for negative rein-
forcement reasons (e.g., escape from stress)
whereas men may be more likely to
engage in addictive behaviors for pos-
itive reinforcement reasons (e.g., seek-
ing a high), and these motivational dif-
ferences may reflect different biologies
and/or result in different clinical presen-
tations. For example, studies link differ-
ences in cortico-striato-limbic activations
in cocaine dependence to stress cues in
women and drug cues in men (48). Addi-
tionally, women more frequently than men
present with other mental health issues,
such as trauma and depression, that co-
occur with addictions (33).
Sex differences may extend to non-
substance or behavioral addictions like
gambling disorder. Women with gam-
bling problems often display a “telescop-
ing” effect similar to women with sub-
stance addictions, whereby females often
initiate recreational behavior at a later
age than men but progress more quickly
into problematic gambling (49, 50). Males
tend to develop problems with “face-to-
face” forms of gambling (e.g., poker or
blackjack), whereas females are more likely
to develop problems with less person-
ally interactive forms [e.g., bingo, keno,
electronic-gambling (slot) machines], with
differences appearing to relate to impaired
control over gender-related behavioral
preferences evident in recreational gam-
blers (49, 51). Taken together, data sug-
gest important gender-related differences
exist that warrant consideration in opti-
mizing policy, prevention, and treatment
initiatives.
When investigating the relationships
between sex, hormones, impulsivity, and
addictions, it will be important to consider
research designs. Impulsivity is a multi-
faceted construct and therefore using tasks
assessing specific aspects of impulsivity is
important (52, 53). Additionally, the rein-
forcer presented may also be an important
variable as males and females may have
different motivations relating to consump-
tion of specific reinforcers, and women
may discount more quickly than men when
rewards are hypothetical. In rodents, no
differences were found between males and
females in premature responding when
the reward was food; however, when the
reward was cocaine, female rats made sig-
nificantly more premature responses (54).
It is unclear whether the increase in prema-
ture responding in female rats for cocaine
was related to cycle phase. High estro-
gen levels may attenuate impulsive action
and depleting male rats of testosterone
may decrease impulsive action (55), but
high estrogen levels have also been asso-
ciated with increased sensitivity to cocaine
(56). Therefore, it is important to deter-
mine whether there are fluctuating levels
of impulsivity across different cycle phases
and how these might relate to addictions.
Additionally, understanding and study-
ing genetic differences (and similarities)
between men and women that may under-
lie behavior and neural activity is impor-
tant. One way to disentangle potential roles
of hormones and genetic factors relat-
ing to impulsivity and addiction involves
manipulating hormone levels by adminis-
tering or blocking cycling hormones and
using hormone replacement therapy, par-
ticularly in females who are in menopause.
Moreover, in preclinical models, the use
of ovariectomized animals and controlled
administration or release of various hor-
mones is possible. Preclinical studies may
effectively disentangle influences of geno-
type (XX, XY) from gonadal phenotype
(ovaries, testes) with respect to impulsivity-
related and addiction-related behaviors
(57). Applying these techniques in longi-
tudinal studies across the life-span in both
females and males could provide impor-
tant insight into developmental sex dif-
ferences in impulsivity and addiction, and
these findings may inform human research
and efforts to develop more effective policy,
prevention, and treatment interventions.
In summary, data demonstrate the
importance of studying sex differences in
addictions and impulsivity and their inter-
actions. While research has progressed in
these areas, there remains a deficit in
understanding sex differences. While NIH
has promoted the study of males and
females in clinical populations, sex dif-
ferences are not uniformly and systemat-
ically investigated and influences of circu-
lating hormones are not routinely docu-
mented. Therefore, it is difficult to deter-
mine which differences may link to hor-
mones and which may link to genetic
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differences between the sexes. In preclin-
ical research, sex differences are often
neglected, which may limit the translation
of preclinical findings into clinical settings.
Routine considerations of sex differences
in preclinical and clinical research settings
will help advance translational efforts and
improve prevention, treatment, and policy
initiatives.
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